Oxidative stress-induced, poly(ADP-ribose) polymerase-dependent upregulation of ET-1 expression in chronic diabetic complications. (scientific article published in June 2008)

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Q27860882

Biochemistry and molecular cell biology of diabetic complications

Q28131781

The enzymatic and DNA binding activity of PARP-1 are not required for NF-kappa B coactivator function

Q28190711

Effects of curcumin on retinal oxidative stress and inflammation in diabetes

Q28567589

Diabetes-induced extracellular matrix protein expression is mediated by transcription coactivator p300

Q28583406

Fibronectin at a glance

Q34150530

The therapeutic potential of poly(ADP-ribose) polymerase inhibitors

Q34838585

Inhibition of the activity of poly(ADP ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle

Q35960752

Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors

Q36111918

Acquired immunodeficiency syndrome and the kidney

Q37940693

Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells

Q38308743

Diabetic cardiomyopathy. A unique entity or a complication of coronary artery disease?

Q40961243

Differential effects of curcumin on vasoactive factors in the diabetic rat heart.

Q42075250

EDB fibronectin and angiogenesis -- a novel mechanistic pathway.

Q42486951

Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly(ADP-ribose) polymerase

Q43764637

High glucose-induced, endothelin-dependent fibronectin synthesis is mediated via NF-kappa B and AP-1.

Q44185271

Differential activation of NF-kappa B and AP-1 in increased fibronectin synthesis in target organs of diabetic complications

Q44312293

Oncofetal fibronectin in diabetic retinopathy.

Q44703286

Acetylation of poly(ADP-ribose) polymerase-1 by p300/CREB-binding protein regulates coactivation of NF-kappaB-dependent transcription

Q46735341

Inhibition of methylazoxymethanol acetate initiation of colon carcinogenesis in rats by treatment with the poly(ADP-ribose)polymerase inhibitor 3-aminobenzamide.

Q53521484

P433

issue

P304

page(s)

365-372

P577

publication date

2008-06-01

P1433

published in

Canadian Journal of Physiology and Pharmacology

Q5030248

P1476

title

Oxidative stress-induced, poly(ADP-ribose) polymerase-dependent upregulation of ET-1 expression in chronic diabetic complications

P478

volume

Reverse relations

cites work (P2860)

Q88646545	Correlation between heat shock proteins, adiponectin, and T lymphocyte cytokine expression in type 2 diabetics
Q92629828	Curcumin as a Therapeutic Option in Retinal Diseases
Q37835424	Endothelin-1 and diabetic complications: focus on the vasculature
Q39048549	Free radical scavenging decreases endothelin-1 excretion and glomerular albumin permeability during type 1 diabetes
Q35707164	Glucagon-Like Peptide 1 Protects against Hyperglycemic-Induced Endothelial-to-Mesenchymal Transition and Improves Myocardial Dysfunction by Suppressing Poly(ADP-Ribose) Polymerase 1 Activity
Q26773988	Hyperglycemic Stress and Carbon Stress in Diabetic Glucotoxicity
Q33552820	Isoproterenol disperses distribution of NADPH oxidase, MMP-9, and pPKCepsilon in the heart, which are mitigated by endothelin receptor antagonist CPU0213
Q43117950	Low-dose erythropoietin inhibits oxidative stress and early vascular changes in the experimental diabetic retina
Q30009025	MicroRNA-23b Targets Ras GTPase-Activating Protein SH3 Domain-Binding Protein 2 to Alleviate Fibrosis and Albuminuria in Diabetic Nephropathy
Q38093867	Oxidative-stress-induced epigenetic changes in chronic diabetic complications
Q41588671	Pancreatic mitochondrial complex I exhibits aberrant hyperactivity in diabetes.
Q33849720	Pathogenesis of chronic hyperglycemia: from reductive stress to oxidative stress
Q51723573	Poly(ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors Reduce Reactive Gliosis and Improve Angiostatin Levels in Retina of Diabetic Rats.
Q26752842	Protein Modifications as Manifestations of Hyperglycemic Glucotoxicity in Diabetes and Its Complications
Q37230827	Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction
Q38168567	Role of poly (ADP-ribose)-polymerase and its signaling pathway with renin-angiotensin aldosterone system in renal diseases
Q64892032	Role of pseudohypoxia in the pathogenesis of type 2 diabetes.
Q42838420	SIRT1 reduction causes renal and retinal injury in diabetes through endothelin 1 and transforming growth factor β1.
Q43273844	Sildenafil decreased cardiac cell apoptosis in diabetic mice: reduction of oxidative stress as a possible mechanism.
Q28076120	Sources and implications of NADH/NAD(+) redox imbalance in diabetes and its complications
Q35404898	miR-146a-Mediated extracellular matrix protein production in chronic diabetes complications.
Q43219265	miR133a regulates cardiomyocyte hypertrophy in diabetes.